Michael Hadley: SCOT-HEART 2 Trail Could Transform How We Think About Identifying Those at Risk of Heart Attacks
Michael Hadley, System Director of Advanced Cardiac Imaging at Northwell Health, shared on LinkedIn:
”The SCOT-HEART 2 trail could transform how we think about identifying those at risk of heart attacks.
This ongoing study is randomizing asymptomatic individuals ages 40-70 with 1 or more risk factors for heart disease to either Coronary CTA or standard care, with appropriate therapies, and following for a primary outcome of heart attack.
If the trial is positive, guidelines could recommend broader CT screening of asymptomatic adults, allowing us to detect and treat coronary disease earlier to prevent more heart attacks.
To prepare, we need to model out what a positive trial could mean for patient volumes and what it would take to meet that need.”
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 10, 2026, 14:33Eugene Tang: A Look at What’s Happening in Life After Stroke Research Across Europe at ELASF 2026
-
Mar 10, 2026, 14:25Ahd Elmahi: Complex Case of Catecholamine-Induced Multiorgan Failure and Arterial Thrombosis in Community-Acquired Pneumonia
-
Mar 10, 2026, 13:36Nirupama Yechoor: How Survivors of Stroke Define Spiritual Wellbeing in Recovery
-
Mar 10, 2026, 13:17Jeannie Devereaux: A Novel Technique for Precise High-Dose PRP Injection in Hip Labral Tear
-
Mar 10, 2026, 13:13Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
-
Mar 10, 2026, 13:08Michael Ertl: Honoured To Be Elected Fellow of the European Stroke Organisation
-
Mar 10, 2026, 13:00Nita Radhakrishnan: Benchmarking Hemophilia Care Across Global Income Settings Using Data from India
-
Mar 10, 2026, 12:59Hisam Siddiqi: Night Sweats Are Not Always a Hematological Plot Twist
-
Mar 10, 2026, 12:54Tzu-Fei Wang: Reassuring Real-World Data for Clinicians to Guide Anticoagulation in Prostate Cancer